All In MedTech

Device Trial Radar · NCT04799418

STEM-PD Open Label Extension (OLE)

Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease: An Open Label Extension (OLE) Study

Last checked: Nov 20, 2026Latest source record: Jul 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

148

Actual

Start

Sep 15, 2022

Primary completion

Feb 24, 2025

Study completion Feb 24, 2025

Sponsor

Lead sponsor
Scion NeuroStimNot on our public-company list
Sponsor type
Industry
First posted
Mar 16, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Conditions

  • Parkinson Disease
  • Parkinson's Disease and Parkinsonism

Interventions

  • Open Label Extension StudyDevice

    This study will investigate the safety and efficacy of extended treatments for the management of symptoms related to PD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS) Total ScoreTime frame: 3 months (NCT04797611 RCT: Day 29 - Day 113; This OLE: Day 113 to Day 197)

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Movement Disorder Center of Arizona

    Scottsdale, Arizona

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.